Transfert des coûts des produits pharmaceutiques des services publics de prestations-maladie aux services privés

Les produits pharmaceutiques se rangent parmi les traitements de santé les plus courants au Canada. Ils représentent également la deuxième dépense de santé en importance et celle dont la croissance est la plus rapide. Les produits pharmaceutiques constituent la plus importante composante des trousses de prestations-maladie offertes par les employeurs, et les employés affirment que […]

Read More
Cost Shifting of Pharmaceuticals from Public to Private Healthcare Payers

Pharmaceuticals are among the most commonly used and important healthcare treatments in Canada. They are also the second largest single healthcare expenditure and are the fastest increasing healthcare expenditure. For employers, pharmaceuticals are the largest component of their health benefits package and employees cite drugs as being the most valuable part of their employer-funded health […]

Read More